Predict your next investment

enorivercapital.com

See what CB Insights has to offer

Investments

16

Portfolio Exits

2

Funds

2

About Eno River Capital

Eno River Capital Headquarter Location

2530 Meridian Parkway

Durham, North Carolina, 27713-5273,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Eno River Capital

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Eno River Capital in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Eno River Capital Investments

16 Investments

Eno River Capital has made 16 investments. Their latest investment was in Bloodhound Technologies as part of their Series E on November 11, 2002.

CBI Logo

Eno River Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/11/2002

Series E

Bloodhound Technologies

$3M

No

4/1/2002

Series A

MxStaffing.com

$1M

No

Undisclosed Angel Investors

1

12/1/2001

Series A

Allvivo Vascular

$1.65M

No

Redmont Venture Partners, and Undisclosed Investors

1

5/8/2001

Unattributed VC

Subscribe to see more

$99M

Subscribe to see more

10

3/1/2001

Seed

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/11/2002

4/1/2002

12/1/2001

5/8/2001

3/1/2001

Round

Series E

Series A

Series A

Unattributed VC

Seed

Company

Bloodhound Technologies

MxStaffing.com

Allvivo Vascular

Subscribe to see more

Subscribe to see more

Amount

$3M

$1M

$1.65M

$99M

$99M

New?

No

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Undisclosed Angel Investors

Redmont Venture Partners, and Undisclosed Investors

Sources

1

1

10

10

Eno River Capital Portfolio Exits

2 Portfolio Exits

Eno River Capital has 2 portfolio exits. Their latest portfolio exit was Bloodhound Technologies on June 07, 2011.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/7/2011

Acquired

$991

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

6/7/2011

00/00/0000

Exit

Acquired

Subscribe to see more

Companies

Subscribe to see more

Valuation

$991

Acquirer

Subscribe to see more

Sources

10

Eno River Capital Fund History

2 Fund Histories

Eno River Capital has 2 funds, including North Carolina Bioscience Investment Fund LLC.

Closing Date

Fund

Fund Type

Status

Amount

Sources

6/1/1999

North Carolina Bioscience Investment Fund LLC

Early-Stage Venture Capital

$26M

1

Eno River Ventures

Subscribe to see more

$99M

10

Closing Date

6/1/1999

Fund

North Carolina Bioscience Investment Fund LLC

Eno River Ventures

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Status

Amount

$26M

$99M

Sources

1

10

Eno River Capital Team

4 Team Members

Eno River Capital has 4 team members, including current Chief Financial Officer, Lisa London.

Name

Work History

Title

Status

Lisa London

Chief Financial Officer

Current

Daniel Egger

Managing Partner

Current

Paul Jones

Managing Partner

Current

Keith Allaun

General Partner

Current

Name

Lisa London

Daniel Egger

Paul Jones

Keith Allaun

Work History

Title

Chief Financial Officer

Managing Partner

Managing Partner

General Partner

Status

Current

Current

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.